Seeing Babymetal with the family tomorrow! We hope to be able to get these to you, #メタラジ!🤟🫶
#Babymetalfans help us get this to them!
#BABYMETALWORLDTOUR2025
#BabyMetalManila2025
#babymetalfanart
2
190
Edhel Tripon retweeted
Exercise before breakfast in the fasting state is more beneficial than postprandial morning exercise for improving liver fat and A1c.
journals.lww.com/acsm-msse/f…
Edhel Tripon retweeted
Another outcomes trial win for GLP-1 medicines now with Semaglutide and the ESSENCE trial in metabolic liver disease with reduction in both inflammation and fibrosis #MASH novonordisk.com/content/nnco…
Edhel Tripon retweeted
Nakwento ko na dati ito dito sa Twitter (X na pala)- pero ngayon ko lang nailagay sa slides.
Kung gusto talaga nating magkaroon ng madaming travel options, kailangan nating simulan sa paglalakad. Pedestrian dapat ang priority. Pedestrian tayong lahat.
nitter.cf/cxteam_lim/status/1603…
Edhel Tripon retweeted
This important study shows three lessons:
🔸Cirrhosis is frequently underdiagnosed.
🔸Alcohol is the leading cause.
🔸HCC is not adequately screened.
Early diagnosis of silent cirrhosis can save lives !
t.ly/8SoPI
Shout out and appreciation to all our extraordinary Radiology friends who go above and beyond, ask questions about the history, and are willing to look again when asked ! You help us solve mysteries and save lives everyday. Can't imagine doing Liver and GI without you guys!
2
84
Reposting for #TLM2024. Taco crawl
This Post is from an account that no longer exists. Learn more
1
155
Edhel Tripon retweeted
Excellent state of the art paper reviewing IV Iron! onlinelibrary.wiley.com/doi/…
Edhel Tripon retweeted
Screening Strategies for High-Risk MASLD in Primary Care are cost-effective.👍💰👍
Pharmaco-economic study:👉onlinelibrary.wiley.com/doi/…
@Echosens @semfyc @SEMERGEN_CV @redGDPS @NovoNordiskES @EASLnews
Edhel Tripon retweeted
How many people visiting diabetes clinic have advanced liver fibrosis?
Lots
Laurent went to diabetes clinic and convinced 300 people to get a liver biopsy. 1 of every 3 had advanced fibrosis
These are the people at risk for liver cancer, ascites, encephalopathy #IMTLD2024
Even more frustrating when you know it's impossible to get one due to access issues :(
It's #OrganDonatiomWeek!! Please consider joining the #OrganDonorRegister. Nearly 8,000 UK children and adults waiting for life saving #transplants. It could be you! Please #ShareYourWishes with your family as they have to give consent. #LiverTwitter. #CKD #Heart #Lungs
1
96
MASLD Natural History
* 3% develop major adverse liver events within 2 decades ( 3 out of 100!)
- seems small - but the MASLD burden is Ginormous!
*Estimated progression to Cirrhosis (for those who progress)
F0-F1 --> 3 decades
F2 --> 2 decades
F3 --> 6 years
This Post is from an account that no longer exists. Learn more
Edhel Tripon retweeted
🚨#livertwitter
#SpleenStiffness Measurement #SSM
by dedicated 100Hz #VCTE #Fibroscan probe improves #PortalHypertension risk assessment
🎯 #NICER model by @mathiasjachs @MattiasMandorf1 for the @BavenoCoop
published @LancetGastroHep
📕t.ly/bL_wv
More options, more reason to MDT for HCC!
New data for #intermediate #HCC at #ESMO24 from LEAP-012 trial
👍🏻PFS/ORR benefit for LenvaPembro+TACE (vs TACE)
🤞🏻OS promising
🤝Toxicity acceptable
👉Systemic+TACE as SOC may be close to be a reality!! (2nd +ve study 😉 EMERALD-1)
@myESMO #ESMOAmbassadors @GrupoTTD @EASLnews
2
67
Edhel Tripon retweeted
TACE +/- lenva + pembro for intermediate-stage HCC
#ESMO24
🔎Phs III LEAP-012
👉ORR 46 vs 33% (RECIST)
👉ORR 71 vs 49% (mRECIST)
👉mPFS 10 vs 14.6 mo
👉mOS not mature
👉AE ≥3 31% vs 71%
🧐strong ORR and PFS data, already practice-changing?
@myESMO #ESMOAmbassadors
Edhel Tripon retweeted
Confused by BRTO, CARTO, PARTO? This slide from Ken Chan is for you!
Just say, "embolization of varices"
#livertwitter #AGW2024
Edhel Tripon retweeted
Less=More w #antibiotics in #cirrhosis & ✅
reconsider #SecSBPProphylaxis
@AmJGastro⤵️
pubmed.ncbi.nlm.nih.gov/3923…
🔑#SecSBPPr vs others▶️⬆️SBP recurrence &🚫mortality benefit
🔑2 datasets (@VAResearch & @TriNetX) w similar trends
🔑worsens over time & validated locally
@ABsteward
Edhel Tripon retweeted
Tirzepatide was associated with 48% decreased kidney events compared to GLP1 RA, in a retrospective analysis of 140,308 patients with type 2 diabetes.
Also with:
⬇️ 20% 🫀MACE
⬇️ 42% ☠️all cause mortality
⬇️ 0.34% a1c
⬇️2.9kg body weight
We need full randomized clinical trials before we can make conclusions of clear superiority
jamanetwork.com/journals/jam…
Edhel Tripon retweeted
Tirzepatide has a greater A1c level and body weight reduction than semaglutide, particularly with the higher doses.
link.springer.com/article/10…
Edhel Tripon retweeted
Two @NEJM papers testing dual/enhanced GLP-1 receptor agonist–based treatments in MASH.
Phase-2 trials on Tirzepatide & Survodutide by @DrLoomba & @ArunJSanyalVCU showed promising results to be confirmed in Phase-3 studies.
t.ly/5Rlyz
t.ly/iH6xv












































